title: Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol.
authors.forename: N
authors.initials: N
authors.lastname: Yasui-Furukori
authors.forename: T
authors.initials: T
authors.lastname: Kondo
authors.forename: A
authors.initials: A
authors.lastname: Suzuki
authors.forename: K
authors.initials: K
authors.lastname: Mihara
authors.forename: N
authors.initials: N
authors.lastname: Tokinaga
authors.forename: Y
authors.initials: Y
authors.lastname: Inoue
authors.forename: K
authors.initials: K
authors.lastname: Otani
authors.forename: S
authors.initials: S
authors.lastname: Kaneko
mesh_terms: D000328:Adult; D000368:Aged; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D005260:Female; D005838:Genotype; D006220:Haloperidol / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy / Q000235:genetics*
chemical_list: D011388:Prolactin; D019389:Cytochrome P-450 CYP2D6; D006220:Haloperidol